| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |